H-labelled estrogen· precursors to the fetal compartment. It was hoped to obtain Information about the quantity and quality of the fetoplacental steroid-metabolism in the direction of fetus to mother. In the past years LAU RITZEN and coworkers [5, 6, 7] have developed a placental function test in which dehydroepiandrosterone-sulfate s an estrogen-precursor was injected into the mother. Thereafter the increase of the estrogen-excretion in the 24-h-urine or the estrogen level in maternal plasma was determined s a parameter of placental metabolic activity [20] . Both urinary and plasma estrogens rose markedly after application of the androgenic steroidprecursor s confirmed by investigators [2, 21, 19] . The DHEA-S induced increase in urinary or plasma estrogens provides Information about the reservecapacity of the placenta. Using incubation studies with placental tissue we could demonstrate in vitro that the conversion of DHEA to estrogens by the placental aromatising enzyme-system is significantly reduced in pathological pregnancies (preeclampsia, diabetes, postmaturity) s compared to normal pregnancies [10, 12, 13] . These studies demonstrated that in complicated pregnancies the diminished capacity of the aromatizing enzymesystem can occur and may result in a reduced estrogen production which is of great clinical importance. Untilnowthe dehydroepiandrosteronetest was performed by precursor application to the maternal compartment i.e. by intravenous injection of DHEA-S into the maternal cubital vein. Since the amniotic fluid has become more easily accessible due to better techniques the possibility of a new placenta function test using intraamniotic DHEA-S injection was examined simultaneously. In the following investigations of 4 normal pregnancies between the 18th to 20th week of gestation, we applied ( 3 H)-labelled dehydroepiandrosterone-sulfate directly into the fetal compartment i.e. intraamniotical. Subsequently these pregnancies were legally terminated by injection of prostaglandine after the test-procedure.
l Materials and methods
After locating the placenta by ultrasonic Vision in 4 patients, ΙΟΟμΟί DHEA-7a-3 H-sulfate (spez. activity 1000 mCi/mmol) + 5 mg DHEA in sterile 0.9% NaCl were injected transabdominally into the amniotic cavity. Ten milliliters of blood was drawn from the cubital vein of the pregnant women before injection and after 15, 30, 60,120, 180 und 240 niinutes into heparinized tubes. After centrifugation 5 ml of plasma was incubated with 5000 IU 0-glucuronidase sulfatase (BOEHRINGER) for 2 hrs. at pH 5.4 and 37°C in a shaking thermostat. Extraction of the total free metabolites was processed three times with ether/chloroform. The extracts were evaporated to dryness and the dry residues were redissolved in warm methanol and pipetted into formamid-saturated paper for chromatography. Separation of C 18 and C 19 -steroids was performed in formamid/monochlorbenzene. The C 18 -steroids were rechromatographed in formamid/chloroform, the C 19 -steroids in propylenglycol/cyclohexan (see KNÜPFEN [4] Estriol (Oe 3 ), DHEA and 16a-OH-DHEA were partially acetylated and identified by recrystallization to constant specific activity. After localization of the metabolites by parallelrunning, labelled test-chromatogramms, extraction from the paper was performed with methanol and radioactivity measured in a liquid-szintillationcounter. The quantity of plasma-steroids was expressed in nCi/100 ml plasma.
Results
The course of the plasma-levels for each steroidfraction during the test-period is shown in Tab. L The values for the 4 isolated C 18 -steroids over the test-period are additionally demonstrated in graphs (see figures). From the C 18 -steroids, the two C 16 hydroxylated compounds, estriol and 16-hydroxyestrone, have been isolated. Seventy-five percent of all originating estrogens were hydroxylated at C 16 . Estradiol-17/3 and estrone were found in approximately the same quantity. In contrast the estriol level was 2 to 3 times higher than that of the other estrogens. The peak plasma concentration of all C 18 -steroids appeared 180 minutes after ( 3 H)-DHEA-S injection with the exception of estrone which reached its maximum concentration slightly earlier, that is after 120 minutes.
From the C 19 -steroid-fr?ction, 16a-hydroxy-DHEA was isolated with highest concentration in plasma. The recovery of unchanged ( 3 H)-DHEA-S, the steroid that had been initially injected, was somewhat lower. The plasma-levels of A 4 -androstenedione and testosterone were almost equal. The plasma-levels of the C 19 -steroids showed the same temporal course äs those of the C 18 -steroids. The highest values were detected at 180 minutes.
Discussion
The fetal adrenal cortex produces 75% of the total DHEA-S which is then primarily C-l 6-hydroxylated in the fetal liver. DHEA-S and 16a-OH-DHEA-S reach the placenta äs estrogen-precursors through the umbilical arteries and are converted via androstenedione and 19-hydroxyandrostenedione to estrogens, mainly to estriol [l, 14, 17, 18] . For this conversion the placenta is provided with the following enzymes arylsulfatase, 3j3-hydroxysteroiddehydrogenase-A 4 -A s -isomerase, 19-hydroxylase and the aromatizing enzymesystem. The additional activity of the placental microsomal enzyme 170-hydroxysteroiddehydrogenase causes formation of testosterone by reduction of androstenedione and also of estradiol-17/3 from estrone [16, 8] . In our injection study we simulated physiological processes described above by applying the labelled and unlabelled DHEA directly to the fetoplacental unit by intraamniotical injection. The quantity of the exogenous hormones administered in our test is within the normal physiological ränge. The normal fetus produces about 70 mg DHEA-S in 24 hrs.; however, we injected 5 mg unlabelled DHEA and measured its metabolites over a 4 hr. period. Only 5 g of labelled DHEA was used to enable qualitative analysis. Previous investigators have shown that prior to the 20th week of gestation the fetus sw.allows significant volumes of amniotic fluid. The high 16 -hydroxylaseactivity of the fetal liver [9, 11] causes C 16 -hydroxylation of 75% of all recovered metabolites (Tab. I): The main 16-hydroxylated metabolite is 16a-OH-DHEA and after placentapassage 16a-OH-estrone and estriol. 15 minutes after intraamniotic injection of DHEA-S a signif-Tab. I. Level of ptaima eUrogcns (nCi/100 ml pla*ma) and of untijrogcnic precu/sors following intraamniotic injcction of 100 jjCi ( J H)-dchydrocpiündroj>tcrone-sulfatc. icant quantity of labelled metabolites appears in the maternal circulation. As illustrated in the graphs, the plasmalevels of the metabolites in all 4 cases tested increased up to 3 hrs. after injection and then decreased rather quickly. Our Interpretation of the results is, that the fetus continously swallows the amniotic fluid (approx. 300-500 ml in the 20 th week fo gestation) containing the dispersed radioactive steroid, metabolizes it and delivers it into the maternal circulation after placental passage. This consecutive release of steroid hormones by the placenta might explain the relatively high levels in maternal plasma over several hours, since the elimination of steroids by the kidney is rapid i.e. within 30 minutes. Twenty five percent of the swallowed DHEA is not C 16 -hydroxylated and therefore seems not to pass the fetal liver and consequently to reach the placenta without 16a-hydroxylation. Here it is converted to A 4 -androstenedionetestosterone and to estrone and estradiol-17/3 via the A 4 -metabolic pathway. These fractions enter the maternal circulation and were identified in plasma äs shown in pregnancies with anencephalic fetuses. In these cases the estriol excretion in 24-hr-urine was significantly lower than in normal pregnancies. Our study shows that the application of labelled estrogen-precursors to the fetal compartment and the following recovery of C 19 -and C J8 -steroids in maternal plasma give valuable Information about thequantity of the fetoplacental steroid-metabolism in midpregnancy.
Summary
In 4 patients with normal pregnancies between the 18th and 20 th weck of gcstation ( 3 H7a)-dehydroepiandrosterone-sulfate (| 3 H]-DHEA-S) was injected intraamniotically. Maternal vcnous blood was drawn before and at rcgulai intcrvals for 240 minutes after DHEA-injection. Thereafter, legal abortion was performed by intraamniotic instilJation of prostaglandine. The conjugated steroids were hydrolyzed enzymatically and the total steroids were isolated and identified.
The following labelled metabolites were determincd quantitativeley: Estriol (E 3 ), estradiol-170 (E 2 -170), estrone (E^, 16 -hydioxy-estrone, (löa-OH-Ej), dehydroepiandrosterone (16a-OH-DHEA), A 4 -androstenedione (AD) and testosterone (T). The maximal increase of all estrogen fractions in maternal plasma occuried 120-180min after intraamniotic injection of the precursor. The most prominent rise of the C 18 -steroids could be shown for estriol. 60-70% of all metabolites were C 16 -hydroxylated. HJ-DHE A-S) a ete faite chez 4 parturientes a la grossesse normale entre la l Seme et 20eme sernaine de gestation. Les grossesses ont ete interrompues legalement par la suite par instillation intraamniotique de prostaglandine. Du sang a ete preleve dans la veine cubitale de la mere a intervalles reguliers avant et jusqu'a 240 min apres Finjection. L'hydrolyse enzymatique s'ensuivit dans le plasma, tous les steroides furent isoles et identifies. Enfin on a mesure quantitativement les metabolites radioactifs: oestriol (E 3 ), oestradiol-17/3 (E 2 -17/3), oestrone (Ei), 16a-hydroxy-oestrone, (löa-OH-Ej), deshydroepiandrosterone (DHEA), 16a-hydroxy-d6shydroepiandrosterone, 16a-OH-DHEA), A 4 -androstenedione (AD) et testosterone (T). L'augmentation maximale de tous les oestrogenes survint dans le plasma 120-180 min apres l'injection du precurseur. La fraction d Oestriol depassa de beaucoup la hausse des äutres steroides C ig , 60-70% de tous les motabolites sont fiydroxyles a C^-E« conclusion on peut constater ä la sraite de rios resultats qu'fl est possible d'obtenir de bonnes indicaetions sur ia quantite et la qualite du metaboiisme steroide foeto-placentaire en administrant des precurseurs oestrogeniques marques de faQon physiologique par le cote foetal et en retrouvant les steroi'des C}9 et Cjg dans le plasma de la mere. 
